Multifunctional all-in-one drug delivery systems for tumor targeting and sequential release of three different anti-tumor drugs.

@article{Fan2016MultifunctionalAD,
  title={Multifunctional all-in-one drug delivery systems for tumor targeting and sequential release of three different anti-tumor drugs.},
  author={Li Fan and Yongsheng Zhang and Fuli Wang and Qian Yang and Jiali Tan and Renata Grifantini and Hong Wu and Chao-jun Song and Boquan Jin},
  journal={Biomaterials},
  year={2016},
  volume={76},
  pages={
          399-407
        }
}

Figures from this paper

Construction and Biological Evaluation of Nanoparticle-Based Tumor Targeting Drug Delivery Systems
TLDR
The principle, advantages, and significance of nanoparticle-based tumor targeting drug delivery system, including passive targeting, active targeting, and stimuli-responsive systems/triggered release are presented.
Spatiotemporally and Sequentially-Controlled Drug Release from Polymer Gatekeeper–Hollow Silica Nanoparticles
TLDR
A sequential combination drug delivery strategy exploiting a pH-triggerable and redox switch to release cargos from hollow silica nanoparticles in a spatiotemporal manner, providing a promising therapeutic approach to overcoming drug resistance during cancer treatment.
Core–Shell Nanoparticles as an Efficient, Sustained, and Triggered Drug-Delivery System
TLDR
Interestingly, it is observed that when HeLa cells were treated with doxorubicin-loaded gold core–polymeric shell NPs and exposed to rf for varying times, the mixture of the two polymeric shell nanoparticles induced more cell death as compared to the cells treated with single nanoparticles, suggesting that such multi-nanoparticle systems can be more efficacious delivery systems instead of a single multicomponent system.
Multifunctional Glyco‐Nanofibers: siRNA Induced Supermolecular Assembly for Codelivery In Vivo
TLDR
This work proves the electrostatic self‐assembly between cationic carbohydrates and polyanionic siRNA to be a convenient and effective strategy to fabricate a single vehicle for safe and effective codelivery of drug/siRNA, which can be used to combine chemo‐ and gene‐therapy against cancers and other diseases.
One-Pot Synthesis of Diphenylalanine-Based Hybrid Nanospheres for Controllable pH- and GSH-Responsive Delivery of Drugs
TLDR
This work reports the first pH- and glutathione-responsive diphenylalanine-based hybrid spheres using natural alginate dialdehyde as the cross-linker to induce self-assembly of FF and an in situ reducer of Au3+ ions into Au nanoparticles (Au NPs).
Ternary cocktail nanoparticles for sequential chemo-photodynamic therapy
TLDR
Such a precise sequential release manner ternary cocktail NPs provided a promising platform for efficient and safe chemo-photodynamic therapy, which serves as a promising drug delivery system to cure cancer in the future.
Functional TiO2 nanocoral architecture for light-activated cancer chemotherapy.
TLDR
This work demonstrates that the therapeutic efficacy of DOX-loadedTiO2 nanocorals is strongly dependent on their loading mode and the chemotherapeutic effect is improved under UV light illumination, which provides a significant breakthrough for future applications of TiO2 as a light activated drug carrier in cancer chemotherapy.
...
...

References

SHOWING 1-10 OF 23 REFERENCES
Stimuli-free programmable drug release for combination chemo-therapy.
TLDR
The loaded dual drugs were demonstrated to be delivered in a sequential manner with specific time intervals between their peak releases, which maximize the synergistic effect of the chemotherapeutic agents and reduced system toxicity.
Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: Sequential delivery of doxorubicin and Bcl-2 siRNA
TLDR
It is confirmed that the CNP platform applied to two different types of drugs results in similar in vivo biodistribution and pharmacokinetics, enhancing treatment in a dose-dependent fashion.
Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA release.
TLDR
It was found that disulfide linkages created during nanoparticle formation enhanced the protection of siRNA from degradation and facilitated site-specific siRNA release in the cytosol by glutathione-mediated reduction.
Nanotechnology in Cancer Drug Delivery and Selective Targeting
TLDR
This review focuses on cell recognizing ability of nanoparticles by various strategies having unique identifying properties that distinguish them from previous anticancer therapies.
Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy.
TLDR
In vitro methyl thiazolyl tetrazolium (MTT) assays and drug-induced apoptosis tests demonstrate the HCPT-loaded nanoparticles suppress cancer cell growth more efficiently than the MPEG-b-PAMAM-DOX prodrugs.
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
TLDR
Recent developments with multifunctional and stimuli-sensitive NDDSs and their therapeutic potential for diseases including cancer, cardiovascular diseases and infectious diseases are highlighted.
A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin
TLDR
This work reports the synthesis of polymer nanoparticles (NPs) that carry precise molar ratios of doxorubicin, camptothecin, and cisplatin that provide the first example of orthogonally triggered release of three drugs from single NPs.
Negatively charged AuNP modified with monoclonal antibody against novel tumor antigen FAT1 for tumor targeting
TLDR
In vitro and in vivo research results showed that the intracellular uptake of negatively charged AuCOOH_mAb198.3 particles is enhanced to a greater extent, providing sufficient evidence for receptor-specific targeting by mAb 198.3, which holds significant potential to improve the treatment of cancer.
Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.
...
...